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THE EFFECTS OF RISPERIDONE ON THE VESTIBULAR SYSTEM OF 
HEALTHY VOLUNTEERS AS ASSESSED BY DYNAMIC COMPUTED 
POSTUROGRAPHY 
JOHN CHARLES CACCAVIELLO 
ABSTRACT 
The pharmacodynamic effects of Risperidone on the vestibular system were 
assessed via dynamic computed posturography in 12 healthy subjects (6 male).   Subjects 
were administered 2 mg, orally, of Risperidone and assessed on the NeuroCom® Balance 
Master© system under varying conditions.  The vestibular response was deductively 
quantified by first assessing balance with a static force plate and eyes closed (Condition 
2), and then assessed on a dynamic force plate with eyes closed (Condition 5).  On 
average, Condition 2 scores were 24.46 points higher than Condition 5 scores (95% CI 
[20.973, 27.957]).  A Pearson correlation between scores in Condition 2 and 5 showed a 
significant, moderate positive correlation (r = .487, p <.001).  A trend analysis showed 
the effect of time, post-dose, on equilibrium score to be linear in nature (p < .001).  In 
conclusion, some, but not all, of the subjects involved in the study experienced 
diminished vestibular control after administration of Risperidone; this may be due to 
phenotypic differences or learning effects.  
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INTRODUCTION 
 Risperidone (RISPERDAL®) is an atypical antipsychotic, a second-generation 
neuroleptic drug, that has been implicated in the treatment of several psychotic disorders 
such as bipolar disorder and schizophrenia [1-3].  Specifically, Risperidone has a 
benzisoxazole chemical structure with robust dopamine-2 (D2), serotonin-2A (5HT2A), 
alpha-1, alpha-2, and histaminergic (H1) receptor antagonism and some histaminergic 
excitation [1-11].  The 5HT2A receptors have its highest concentrations in the cortex [3].  
Additionally, its “atypical” classification is due to its lower susceptibility to promote 
extrapyramidal side effects (e.g. tremor and dyskinesia) [1, 3].  Linear increases of such 
symptoms have been shown with increasing dosage increments of Risperidone, with a 
peak dose time of around 6 hours,  correlating with the most significant effect on 
vestibular response (in terms of balance assessment) [3].  A dose of 6mg per day has been 
shown to pose the minimal amount of risk of extrapyramidal symptoms for most patients 
[3].  Risperidone has an approximate half-life of 20-30 hours with effects on D2 and 
5HT21 receptor antagonism in the mesolimbic dopamine pathway and cerebral cortex, 
via the mesocortical and nigrostriatal tracks, respectively [1-9].  In relation to this study, 
it’s important to note that Risperidone has been linked to high resting energy expenditure 
and total energy expenditure in the mouse model along with a reduction in locomotor 
activity [8]. 
 To the author’s knowledge, there is no primary literature on the effect of 
Risperidone on the vestibular system, in the human primate or the Mammalia class in 
general.  Balance control and postural stability provide a means in which the effects of 
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Risperidone on the vestibular system can be assessed.  Postural stability is defined as the 
threshold that an individual is able to maintain his or her Center of Mass (COM) over a 
given base of support that incorporates the regulation of the oscillation of the body’s 
Center of Pressure (COP) [3, 12-15].  This involves coordination of feedback from visual, 
vestibular, and somatosensory systems, along with central nervous system processing and 
musculoskeletal responses [3, 12, 13, 16-18].  Thus, technologies that detect center of 
pressure displacement are able to provide information on balance [3, 13]. 
Past postural studies have focused on falls in the elderly population [5, 19-22].  
One particularly common device for measuring postural stability is the Neurocom© 
Balance Master™ system (BM).  The BM system uses a force plate platform that 
localizes an individual’s Center of Gravity (COG) and provides balance and 
posturography assessments  [3, 15, 23-25].  When an individual sways, the 
vestibulospinal system will perform corrective postural adjustments via the relevant 
musculoskeletal responses [16].  On such a platform, forces put on the tibialis anterior 
and triceps surae muscles are key components in the calculation of the Center of Mass 
(COM)  [26].  The BM system been used to interrogate the vestibular system within the 
elderly population [3, 22, 27-34], stroke patients [35-37], patients with vertigo [38], 
caffeine consumption [39], Parkinsonian patients [18, 40], patients that experience 
dizziness [28, 41], spinal cord injury patients [15], cerebellar-pontine-angle-tumor 
patients [34, 42], concussion patients [43, 44], advanced dementia [3], and patients with 
traumatic brain injury [23, 43, 45].   
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The vestibular system consists of the otolith organs of the inner ear and the 
associated nerves that lead to nuclei within the spinal cord.  Specifically, linear 
accelerations are sensed by the utricle and the saccule, which sense translational motion 
and gravitational accelerations respectively [46-58].  Studies have shown the otolith 
organs to primarily be involved with the perception of spatial orientation, determination 
of the subjective vertical and horizontal, modulation of velocity storage, the vestibule-
ocular reflex during linear movements, and maintenance of postural tonus [52, 54, 57, 59, 
60].  These linear accelerometer neurons can also function as a one-dimensional angular 
velocity detector that would be responsible for the generation of ocular reflexes during 
linear vertical acceleration [54, 61, 62].  Otolith function may not be as clear-cut, 
however, due to some otolith-sensitive vestibular nuclei responding to stimulus vectors 
on a plane (i.e. two dimensions) rather than solely on a horizontal or vertical vector (i.e. 
one dimension) [54, 61, 62].  This will prove to be important when discussing where 
Risperidone may have its effect on the vestibular system. 
  In contrast, the three semicircular canals (horizontal/lateral, posterior, and 
anterior/superior) provide angular head velocity information [53, 55-58, 63].  The lateral, 
posterior, and anterior semicircular canals provide information on the rotation of the head 
around a vertical axis (transverse plane), around an anterior-posterior axis (coronal 
plane), and a lateral axis (sagittal plane), respectively.  Since the otolith organs and 
semicircular canals occupy a similar anatomical region in the inner ear, and since some 
stimuli may activate both systems, nerve transmission can overlap.  In the common house 
cat (Felis catus), more than 30% of vestibular neurons receive input from the superior 
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semicircular canal/otolith nerve pairs while half received input from horizontal 
semicircular canal/nerve pairs [53, 64, 65].  The superior/otolith pair projected to the 
ipsilateral lateral and medial vestibulospinal tracts [53, 64, 65].  Although these studies 
were conducted with cats, one may infer that similar neuroconnectivity occurs in the 
human with both being in the Mammalian class.  The human tracts are more difficult to 
define and more difficult to trace in postmortem analysis.  However, studies comparing 
other pathways implicated in neurological disease (i.e. vision, somatosensation, and 
motor tracts) have shown to be relatively conserved in mammals with main differences 
being the anatomical orientation/organization of specific nuclei and tracts rather than the 
pathways themselves.  
As stated previously, Risperidone has robust D2, 5HT2A, alpha-1, alpha-2, and 
H1 receptor antagonism along with some excitation of specific vestibular nuclei.  More 
specifically, in terms of vestibular nuclei in relation to specific neurotransmitters, studies 
have shown: (1) inhibition of the lateral vestibular nucleus (LVN), also known as Deiter’s 
nucleus,  by 5HT derived from the dorsal raphe nucleus [66]; (2) excitation of the inferior 
vestibular nucleus (IVN) by histamine at H1 receptors [67-69]; (3) an abundance of 
dopamine and serotonin receptors in the medial vestibular nucleus [70]; and (4) excitation 
and inhibition of the superior vestibular nucleus (SVN) with 5HT application that is 
receptor dependent [71].   In terms of vestibular nuclei in relation to specific activation 
patterns, studies have shown: (1) excitation of the LVN during saccular activation [72]; 
(2) 15-50% cell activation in the MVN and SVN nuclei during pitch oscillation [73, 74]; 
and lastly, (3) the activation of 110 cells responding to vertical rotation, 103 in which 
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were located in the LVN  [75] and the rostral portion of the IVN [76, 77].  Effects on the 
LVN are especially important due to equilibratory reflexes, via the lateral Vestibulospinal 
tract, associated with it (spinal reflex activity and extensor muscle tone). 
Neurocom’s Sensory Organization Test (SOT) of the BM system provides a 
means by which posturography can be used to test the vestibulospinal pathways that 
control posture [16, 18, 21, 22, 25, 78].  This is usually accomplished by taking 
advantage of the two main ways in which people synchronize their movements: (1) the 
“ankle strategy” which takes advantage of whole body antero-posterior sway through the 
ankles; and (2) the “hip strategy” which takes advantage of the same sway through the 
hip [21, 22, 78].  The moving platform (a computer-controlled plate that, in some test 
conditions, moves in phase with the participant’s pitch rotation) during the SOT tasks 
challenges maximum anterior-posterior sway angles that effect center of gravity 
alignment, and the results of the test are presented in the form of an equilibrium score [3, 
78].  This is accomplished with: (1) the person’s eyes open or closed; (2) with the 
platform static or dynamic; and (3) with the surroundings static or dynamic.  This creates 
six potential combinations of dynamical situations.  The score is calculated from the 
theoretical range of antero-posterior sway (12.5 degrees before losing balance) derived 
from measuring the forces under the feet.  This is expressed as a unitless score between 0 
and 100 with 100 corresponding to no sway, and a fall corresponding to a score of zero.   
A score of 100 indicates ankle strategy with no horizontal shear force on the force plate.  
A score approaching 0 indicates hip strategy with significant horizontal shear forces.  
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Studies have shown that in the pitch direction, somatosensory input is vital for posture 
(especially for standing and walking) [16, 35, 79]. 
Post-hoc, the importance of the superior semicircular canal in relation to the 
human vestibular system was looked into, and the BM was used to target the superior 
semicircular canals by applying the SOT. The specific SOT endpoints used were for the 
subjects’ eyes open as a static control and closed while standing on a platform angulating 
in the pitch axis, dynamic condition, due to the superior canal responding maximally to 
sagittal plane rotation.  
  Risperidone was looked into posthoc to examine effects, if any, on the specific 
vestibular nuclei associated with the superior semicircular canal.   It’s important to note, 
in a similar study using a 3D turntable, that otoliths were also activated by the perception 
of head rotation due to the sense of change in direction of the gravity vector  [80].  
Another study looking into cutaneomuscular reflexes in the anterior and posterior leg, 
following stimulation of the sural nerve, during tilts in the pitch axis showed crossed 
reflexes originating from activation of otolith receptors [81, 82].  To this end, studies 
have shown that there are canal-otolith interactions [83].  More specifically, gravitational 
vestibular signals from the saccule, as well as pitch rotation from the superior 
semicircular canal, are interpreted by the vestibular system to create an accurate 
estimation of tilt and linear acceleration [83].   Due to the outcome of these studies, 
saccular otolith activation will also be taken into account with respect to Risperidone’s 
effects on the vestibular system.  
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It’s important to note that the data collected are used in an attempt to localize 
vestibular response amongst other systems such as visual, auditory, and somatosensory 
input.   However, one can’t rule out the effects of tactile stimulation (via the plantar 
surface of the foot) on the moving platform. Such consideration will be taken up during 
the discussion.  The control for vision is vital to the focus on vestibular stimulation.  The 
six external eye muscles are on three perpendicular planes that approximately fit the 
planes of the three semicircular canals [84].  The vestibulo-oculomotor reflex also has 
three pairs of subsystems that have an excitatory and inhibitory component.  More 
specifically, the excitatory components pair a specific semicircular canal to specific 
external eye muscles that create a compensatory eye movement in the plane of the 
corresponding semicircular canal while the inhibitory component corresponds to the 
antagonists [85-89].  As a result, compensatory eye movement moves in the opposite 
direction of angular and/or linear acceleration of the head [90].  Thus, minimizing visual 
input should decrease the chances of the vestibulo-oculomotor reflex being activated and 
activating additional circuitry.   
With this, this study will build on the understanding of reliable, consistent, and 
accurate methodologies that are required to assess balance, gait, and the vestibulospinal 
system.  It is hypothesized that the administration of Risperidone will negatively affect 
equilibrium scores during BM assessment.  This is hypothesized due to the drug’s effects 
on D2 and alpha 2 receptors which are both implicated in balance and posture. 
Furthermore, assessing gait and balance using mobile sensing devices, with and without 
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Risperidone, will be used to further future research (i.e. with the decline in semicircular 
canal and otolith function with age associated with increased postural sway) [91, 92].  
METHODOLOGY 
Subjects: 
This study was approved by the Institutional Review Board (IRB) and Ethics 
Committee (EC), and the permit number of IRB is H-34387.  All participants provided 
written consent on their own accord along with written consent in order to participate in 
the study.  The consent process was approved by the IRB.  Subjects consisted of 6 males 
and 6 females (mean age: 25.5 +/- 3.94; range 18-34).  Phone interviews were used to 
assess perspective subject inclusion and exclusion criteria and took approximately 10 
minutes to complete.  Exclusion criteria included: (1) evidence or history of clinically 
significant diseases (including drug allergies, but excluding untreated, asymptomatic, 
seasonal allergies at time of dosing); (2) any condition possibly affecting drug absorption; 
(3) history of regular alcohol consumption exceeding 7 drinks/week for females or 14 
drinks/week for men within 6 months of screening; (4) use of tobacco- or nicotine-
containing products in excess of the equivalent of 5 cigarettes per day; (5) history of 
substance abuse and/or dependence; (6) History of movement disorder or family history 
of movement disorder; (7) history of prior treatment with an antipsychotic agent; (8) 
treatment with an investigational drug within 30 days preceding the first dose of trial 
medication; and (8) pregnant women. 
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 For each subjects’ screening, performed at intake, a 12-lead ECG demonstrating 
QTc <450 msec was needed in order to initiate the study process along with evidence of a 
signed informed consent document, a Body Mass Index (BMI) of approximately 18 to 30 
kg/m2 was needed, and vital signs were performed (each task taking approximately 5-10 
minutes).  Immediately after the intake process, baseline assessment of each subjects’ 
motor behavior was assessed using the BioSensics, Balance Master, the Tinetti 
instrument, and the Extrapyramidal Symptom Rating Scale Abbreviated (ESRS-A) 
(approximately 30-45 minutes to complete).  
Treatment Description and Condition of Evaluation: 
 During each subject’s first study date, a dose of 2mg (oral tablet) of Risperidone 
will be administered immediately after the baseline assessment with post dose 
assessments occurring at 2 hours post-dose (peak dose), 6 hours post-dose, and 24 hours 
post-dose using the BalanSens™ system (BioSensics LLC, Cambridge MA), SMART 
Balance Master™ (NeuroCom, Pleasanton CA), and ESRS-A instruments.   An onsite 
neurologist monitored subjects after the dose was administered.  Subjects remained in the 
laboratory for 7 hours post administration and were released to an accompanying escort.  
Subjects returned the next day for a follow up, and they performed the same tasks as 
baseline (30-45 minutes to complete).  Participants were given $10 USD for lunch, had 
access to on site non-caffeinated beverages between tasks, and were allowed to nap, if 
desired, between assessments.  
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 Protocols were executed and rated by qualified researchers and an onsite clinician.  
Researchers underwent training on the assessments before being permitted to carry out 
the protocol.  
Clinical Assessment and Balance Master Assessments:   
 The SMART Balance Master system and BioSensics system were used for a 
series of assessments that included: (1) the Sensory Organization Test (SOT) which gives 
information on postural control under a variety of sensory conditions; (2) the Adaptation 
Test (ADT) and Motor Control Test (MCT) which give information on the ability of the 
automatic motor system to adapt and recover from a loss of balance following 
unexpected external disturbances; (3) the Limits of Stability (LoS) which is a postural 
stability test that gives information on the maximum distance a subject can displace their 
Center of Gravity (COG) without stepping, reaching for assistance, or falling; (4) the 
ESRS-A; (5) the Tinetti Balance Assessment Tool; and (6) a BioSensics gait task that 
includes the timed up and go task (TUG).   
In this discussion, the SOT is the only endpoint looked into for the BM system, 
and the other tasks are mentioned here for completion.  The SOT, ADT, and MCT tasks 
assess neurological disease, visual disorders, vestibular disorders, somatosensory 
disorders, and head injury.  The LoS and gait tasks are used to assess musculoskeletal 
and/or neurological disorders.  BioSensics mobile sensing devices were attached to 
subjects while performed the BM tasks and the ESRS-A. 
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The ESRS-A was developed to assess a few drug-induced movement disorders 
including Parkinsonism, akathisia, dystonia, and tardive dyskinesia [93, 94].  The 
assessment includes analysis for: (1) hypokinetic Parkinsonism; (2) orofacial dyskinesia; 
(3) trunk/limb dyskinesia; (4) akathisia; (5) tremor; and (6) tardive dystonia [93, 94]. This 
rating scale rates symptoms from 0-6 in terms of severity and frequency (with higher 
scores indicating higher severity and vice versa) [93, 94].  The Tinetti was developed to 
assess fall risk via gait and balance [95, 96].  The assessment includes balance activities 
such as seated, rising, immediate standing, standing, nudged, eyes closed, turning 360 
degrees, and seated [95, 96].  It also includes gait activities such as indication of gait, step 
length and height, foot clearance, step symmetry, step continuity, path, trunk, and 
walking time.  Each is measured on a scale from 0 to 2 (abnormal to normal), and the 
total score indicates risk of fall with a score less than or equal to 18 being a high risk, 19-
23 a moderate risk, and greater than or equal to 24 a low risk  [95, 96].  
Sensory Organization Test:  
The SOT tests one’s ability to use the somatosensory, visual, and vestibular 
system for postural control.  Specifically, sensory organization is the ability to process 
individual sensory system inputs in order to maintain balance control.  This is 
accomplished by suppressing specific sensory cues, such as vision, and selecting cues 
that provide maximum information in order to maintain balance.  The SOT systematically 
isolates and quantifies the use of each sensory modality and shows the individuals’ 
response to each.  Information delivered to the subjects’ eyes, feet, and joints are 
eliminated through calibrated “sway referencing” of the support surface and/or visual 
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surround which tilt to directly follow the subjects’ pitch sway. By controlling for vision 
and proprioception through sway referencing and/or eyes open/closed conditions, the 
protocol eliminates useful visual and/or support surface information [3, 28].   
The system computes the Center of Pressure (COP) data which is, as defined by 
Corbeil, et al. (2012) as “the point of application of the force vector and is equivalent to 
the sum of all the forces acting between the feet and the platform base.”  Such changes in 
CP show the sway of the subject, along with the subject’s corrective musculoskeletal 
mechanism, used to maintain his/her Center of Gravity (COG).  Subjects were instructed 
to stand as still as possible with their feet 10 centimeters apart (hip length apart).  The six 
conditions include: (1) eyes open with fixed surrounding and support (somatosensation); 
(2) eyes closed with fixed support (somatosensation); (3) sway-referenced surroundings 
with fixed support (somatosensation); (4) eyes open with fixed surroundings and sway-
referenced support (vision); (5) eyes closed with sway-referenced support (vestibular); 
and (6) sway-referenced surroundings and support (vestibular) (Figure 1). 
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Figure 1: Sensory Organization Test Conditions. Courtesy of NeuroCom® 
 
In order to study vestibular inputs exclusively, vision was used as a control and 
the body was moved with the feet in a fixed position.  More specifically, condition 2 and 
condition 5 were compared to assess the subjects’ ability to use vestibular input to in 
order to maintain balance [25].  By computing sensory ratios between the average 
equilibrium scores on this pair of sensory test conditions, vestibular function can be 
analyzed [25].  
Risks: 
Electrocardiogram, blood pressure, and vital are taken before the initiation of the 
study, and subjects are excluded from the study if exclusion criteria are met.  
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Furthermore, an on-call physician was on-site in the case of a subject(s) having adverse 
effects to Risperidone.  Risks associated with Risperidone include anxiety, somnolence, 
extra-pyramidal symptoms, dizziness, constipation, nausea, dyspepsia, rhinitis, rash and 
tachycardia in schizophrenia and somnolence, dizziness, parkinsonism, saliva increased, 
akathisia, abdominal pain and urinary incontinence in bipolar mania.  There is fall risk 
associated with BM system and gait tasks; however, to minimize the risk of fall during 
the BM tasks, subjects are harnessed within the BM system.  During gait tasks, a clinician 
and 2 research assistants were present to monitor and protect the subject from harm.   
RESULTS 
 Statistical analyses were performed using SPSS 20.0.0.1 (IBM, Armonk, NY, 
USA). Data was not imputed, as subjects were replaced and excluded from analysis if 
they did not complete the study in full.  Equilibrium scores were higher during Condition 
2 (Eyes closed, static plate) than during Condition 5 (Eyes closed, dynamic plate), as 
expected (Figure 2).  
A Paired t-test suggests a significant average difference between Condition 2 & 
Condition 5 Equilibrium scores (t = 14.1, p <.001). On average, Condition 2 scores were 
24.46 points higher than Condition 5 scores (95% CI [20.973, 27.957]) (Table 2). 
A Pearson correlation between Condition 2 Equilibrium Score and Condition 5 
Equilibrium Score indicated a significant, moderately positive correlation between scores 
at each timepoint, when paired by subject (r = .487, p < .001) (Table 3). 
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A Multivariate Analysis of Variance (MANOVA) indicates a significant effect of 
Time (p < .001), in addition to a significant interaction between Time and Condition (p < 
.001) (Table 4).  A Trend Analysis suggests that the time trend is Linear (p < .001), and 
nearly Quadratic (p = .083), in nature (Table 5). 
 
 
 
 
 
 
 
 
Figure 2: Mean Equilibrium Scores for Conditions 2 & 5 across time 
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Paired Samples Test 
 Paired Differences t df Sig. 
(2-
tailed) 
Mean Std. 
Deviat
ion 
Std. 
Error 
Mean 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper 
 Condition 2 – 
Condition 5 
24.46 12.025 1.7357 20.973 27.957 14.1 47 .000 
 
 
 
Paired Samples Correlations 
 N Correlation Sig. 
 Condition 2 & Condition 5 48 .487 <.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table 2: Pearson correlation between Condition 2 and Condition 
5 across all timepoints 
Table 1: Paired t-test between Condition 2 and Condition 5 scores, paired by 
subject. 
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Multivariate Tests of Time and Conditiona 
Effect Value F Hypothesis 
df 
Error df Sig. 
Time Pillai's Trace .760 21.103b 3.000 20.000 .000 
Wilks' Lambda .240 21.103b 3.000 20.000 .000 
Hotelling's 
Trace 
3.165 21.103b 3.000 20.000 .000 
Roy's Largest 
Root 
3.165 21.103b 3.000 20.000 .000 
Time * 
Condition 
Pillai's Trace .673 13.715b 3.000 20.000 .000 
Wilks' Lambda .327 13.715b 3.000 20.000 .000 
Hotelling's 
Trace 
2.057 13.715b 3.000 20.000 .000 
Roy's Largest 
Root 
2.057 13.715b 3.000 20.000 .000 
 
a. Design: Intercept + Condition  
 Within Subjects Design: Time 
b. Exact statistic 
 
 
  
 
 
 
 
 
 
 
 
 
Table 3: Multivariate Tests of Time and Condition 
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Tests of Within-Subjects Contrasts 
Measure:   MEASURE_1   
Source Time Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Time Linear 630.972 1 630.972 26.017 .000 
Quadrati
c 
120.751 1 120.751 3.293 .083 
Cubic 115.706 1 115.706 2.325 .142 
Time * 
Condition 
Linear 551.122 1 551.122 22.725 .000 
Quadrati
c 
12.279 1 12.279 .335 .569 
Cubic 104.222 1 104.222 2.094 .162 
Error(Time) Linear 533.544 22 24.252   
Quadrati
c 
806.720 22 36.669   
Cubic 1094.822 22 49.765   
 
 
 
Discussion: 
Interpretation of Abnormal Equilibrium Scores: 
 Abnormal equilibrium scores may be due to a variety of confounding variables.  
Such variables include possible sensory dysfunction that may originate as distal as 
primary sensory receptor dysfunction or as proximal as a disorder within the central 
nervous system.  However, this is unlikely given the population of healthy volunteer 
Table 4: Trend Analysis of Within-Subjects Contrasts 
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along with taking into account the inclusion and exclusion criteria.  However, a vestibular 
dysfunction may be present in which in the absence of visual input and/or somatosensory 
input, the subject has significantly reduced balance.  More specifically, this can be tested 
when comparing SOT condition 5 with the control (condition 2) where the subject is not 
able to use vestibular cues to maximize balance control. 
It’s important to note that unusual body movements that cause abnormal sway can 
lead to low equilibrium scores.  Administrators of the tasks were trained to document any 
unusual movements that may have had an effect on the equilibrium scores.   
Sensory Effects: 
 When a subject is on a stable force plate (SOT condition 2), the following 
represent the percentage of sensory information one uses to maintain balance: 70% 
somatosensory; 20% vestibular; 10% visual [16, 97].  When the force plate becomes 
unstable and somatosensory accuracy was made less accurate through its movements 
(SOT condition 5), the relative weights shift to: 60% vestibular; 30% visual; and 10% 
somatosensory  [16, 97].  When vision and proprioception were available to the subject, 
little sway was noted in the population as a whole.  In contrast, when vision was blocked, 
the subjects’ vestibular system took over and the largest sway movement were noted.  
Thus, when it comes to postural adjustments, vision doesn’t seem to be the prominent 
sensory modality in comparison to the somatosensory and vestibular pathways. 
With this, it can be stated that when the input from a specific sensory modality is 
compromised, the nervous system will recalibrate in response to its sensory input in order 
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to reorganize each input’s relative weights in order to maintain postural stability [16].  
This is relevant since relevant muscular responses are a product of the CNS updating 
postural adjustments in response to sensory input.  As an example given by Chien, 2014, 
the somatosensory system can’t tell the difference between movement of the force plate 
and movement of the body.  However, visual input can be used to provide self-motion 
information to one’s body that does not reply on information from the support plate [16].  
In particular relevance to this study, manipulating vision has been show to affect postural 
control exclusively in the sagittal plane and not in the frontal or coronel planes [16, 79, 
98].  Studies have shown a reciprocal inhibitory visual-vestibular interaction and has 
been implicated as a multisensory mechanism for self-motion perception [99, 100].   
 It’s important to note that tactile feedback from the plantar surface of the foot may 
have an effect on the equilibrium score.  Research has shown that such feedback may be 
a contributor to balance and postural stability during the static and dynamic tasks of the 
Balance Master assessment [12].   Somatosensory stimulation from the safety harness 
may also have played a factor [16, 79]. 
 In summary, the central nervous system has multiple sensory modalities that it 
uses to ensure that one’s body can remain upright.  When the number of modalities made 
available increases, integration of modalities ensures that balance and posture can be 
maintained via more accurate postural adjustments.  Thus, during certain tasks, 
modalities that are not as useful are given less weight and vice versa.  Such information is 
important when taking into account patients with possible vestibular, somatosensory, or 
vision disorders. 
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Relevant Neuroanatomy: 
 The axons innervating the different vestibular end-organs are distributed to 
multiple parts to the vestibular cortex with much overlap [101-107].  Axon fibers 
innervating the saccule are located most laterally in the ascending and descending 
branches of the vestibular root fibers, and those innervating the utricle are located more 
medially.  From medial to lateral, the anterior, horizontal, and posterior semicircular 
canal fibers are found.  Furthermore, connections between the superior, medial, and 
spinal vestibular nuclei are reciprocally connected [108].  A future area of research may 
look into the nucleus pepositus hypoglossi which receives input from all of the vestibular 
nuclei as well as the cerebellum, motor pathways specific to controlling eye and head 
movements, and visual and proprioceptive pathways [109, 110].  Nucleus pepositus 
hypoglossi and the perihypoglossal nuclei, and vice versa, project to virtually all parts of 
the vestibular nuclei [109, 110] 
Effects of Atypical Antipsychotics  
 Subjects who are administered atypical antipsychotics typically show low 
incidence of observable extrapyramidal symptoms (EPS) [3].  This may be due to lack of 
precision on the assessments used to assess such symptoms or due to the subjectivity of 
particular clinician or researcher.  As indicated by the ESRS-A compiled results, our 
population as a whole experienced a very low incidence of EPS.  However, two 
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participants dropped out of the study due to the drug’s effects on their standing balance 
and due to feelings of vertigo.  Other subjects reported similar symptoms but were able to 
move on with the study. 
Improvements and Future Studies: 
In terms of limitations and possible confounds, anxiety could have been 
responsible for lower equilibrium scores due to participants being subjected to novel 
stimuli (e.g. a foreign laboratory environment or a curious pill ingestion).  Additionally, 
there may have been learning effects due to repetitive administrations of tasks (four 
administrations of experimental protocol in two days). Labs that specialize in molecular 
neurobiology should build on and focus on the specific nuclei, that may be effected by 
Risperidone, as described previously.   
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